Susan C. Morpeth

9.4k total citations
46 papers, 1.8k citations indexed

About

Susan C. Morpeth is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, Susan C. Morpeth has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 24 papers in Epidemiology and 5 papers in Microbiology. Recurrent topics in Susan C. Morpeth's work include Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (8 papers) and COVID-19 Clinical Research Studies (8 papers). Susan C. Morpeth is often cited by papers focused on Pneumonia and Respiratory Infections (14 papers), Respiratory viral infections research (8 papers) and COVID-19 Clinical Research Studies (8 papers). Susan C. Morpeth collaborates with scholars based in Kenya, United Kingdom and New Zealand. Susan C. Morpeth's co-authors include John A. Crump, Habib O. Ramadhani, J. Anthony G. Scott, Neema Mturi, John Bartlett, John F. Shao, Laura L. Hammitt, Angela Karani, Salim Mwarumba and James A. Berkley and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Susan C. Morpeth

44 papers receiving 1.7k citations

Peers

Countries citing papers authored by Susan C. Morpeth

Since Specialization

Citations

This map shows the geographic impact of Susan C. Morpeth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan C. Morpeth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan C. Morpeth more than expected).

Fields of papers citing papers by Susan C. Morpeth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan C. Morpeth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan C. Morpeth. The network helps show where Susan C. Morpeth may publish in the future.

Co-authorship network of co-authors of Susan C. Morpeth

This figure shows the co-authorship network connecting the top 25 collaborators of Susan C. Morpeth. A scholar is included among the top collaborators of Susan C. Morpeth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan C. Morpeth. Susan C. Morpeth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate	Clinical Microbiology and Infection	Susan C. Morpeth, Balasubramanian Venkatesh et al.	5
2	TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trials		Susan C. Morpeth, Thomas Hills et al.	1
3	Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review	Clinical Pharmacokinetics	Steven Y. C. Tong, Justin T. Denholm et al.	17
4	ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial	Trials	Justin T. Denholm, Balasubramanian Venkatesh et al.	6
5	Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand	Clinical & Translational Immunology	Alana L. Whitcombe, Reuben McGregor et al.	33
6	SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study	Pathology	Dragana Drinković, Catherine Jackson et al.	14
7	Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New Zealand	PeerJ	Reuben McGregor, Alana L. Whitcombe et al.	8
8	Invasive Cronobacter species infection in infants and children admitted to a rural Kenyan hospital with a high prevalence of malnutrition	Paediatrics and International Child Health	Joseph Piper, Salim Mwarumba et al.	3
9	Bacteriological diagnosis of childhood TB: a prospective observational study	Scientific Reports	Andrew Brent, Daisy Mugo et al.	14
10	Molecular epidemiology of Klebsiella pneumoniae invasive infections over a decade at Kilifi County Hospital in Kenya	International Journal of Medical Microbiology	Christine J. Boinett, Matthew J. Ellington et al.	51
11	Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study	The Lancet Global Health	Laura L. Hammitt, Angela Karani et al.	33
12	Making standards for quantitative real-time pneumococcal PCR	SHILAP Revista de lepidopterología	Susan C. Morpeth, Jim F. Huggett et al.	9
13	Population Genetic Structure of Streptococcus pneumoniae in Kilifi, Kenya, Prior to the Introduction of Pneumococcal Conjugate Vaccine	PLoS ONE	Angela B. Brueggemann, Benard W. Kulohoma et al.	14
14	Treatment Failure Among Kenyan Children With Severe Pneumonia—A Cohort Study	The Pediatric Infectious Disease Journal	C. Webb, Mwanajuma Ngama et al.	28
15	The Role of Postmortem Studies in Pneumonia Etiology Research	Clinical Infectious Diseases	Gareth D. H. Turner, Charatdao Bunthi et al.	40
16	High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya	BMC Infectious Diseases	Daniel R. Feikin, Barrack Aura et al.	31
17	Morbidity and mortality among a cohort of HIV-infected adults in a programme for community home-based care, in the Kilimanjaro Region of Tanzania (2003–2005)	Annals of Tropical Medicine and Parasitology	L. Gayani Tillekeratne, Nathan M. Thielman et al.	9
18	Effect of Trimethoprim-Sulfamethoxazole Prophylaxis on Antimicrobial Resistance of Fecal Escherichia coli in HIV-Infected Patients in Tanzania	JAIDS Journal of Acquired Immune Deficiency Syndromes	Susan C. Morpeth, Nathan M. Thielman et al.	15
19	Predicting CD4 Lymphocyte Count <200 Cells/mm ³ in an HIV Type 1-Infected African Population	AIDS Research and Human Retroviruses	Susan C. Morpeth, John A. Crump et al.	14
20	Diarrhea in patients with AIDS	Current Treatment Options in Gastroenterology	Susan C. Morpeth, Nathan M. Thielman	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact